Maurie Markman
Gynecologic Oncology · Houston, TXNPI 1669564696
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (49.2%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by AstraZeneca at 34.9% of the total. Reporting peaked in 2019 at $84,350 and has fallen 98.1% since, to $1,600 in 2025. Among gynecologic oncology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 132 payments — averaging $1544.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$71K
- GSK$54K
- Genentech USA, Inc.$31K
- Clovis Oncology, Inc.$20K
- Merck$18K
- Myriad Genetic Laboratories, Inc.$7K
- plus $3K from 3 others
What the payments were for
- Consulting fees$100,37549%
- Speaking & faculty fees$86,37842%
- Travel & lodging$15,3628%
- Food & beverage$1,8031%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 50 | $71,130 |
| GSK | 23 | $54,108 |
| Genentech USA, Inc. | 19 | $31,496 |
| Clovis Oncology, Inc. | 15 | $19,721 |
| Merck | 17 | $17,623 |
| Myriad Genetic Laboratories, Inc. | 4 | $6,854 |
| Amgen | 2 | $2,596 |
| La Jolla Pharmaceutical Company | 1 | $263 |
| Novartis | 1 | $127 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$203,917 in reported general payments places this provider in the 95th percentile of 135 gynecologic oncology providers in Texas.
Other gynecologic oncology in Houston
- Robert ColemanHouston$864K
- Michael FrumovitzHouston$156K
- Aparna KamatHouston$116K
- Anuj SuriHouston$72K
- Anil SoodHouston$69K
- Pedro RamirezHouston$42K
- Pamela SolimanHouston$37K
- Anthony CostalesHouston$17K
- Travis SimsHouston$14K
- Lois RamondettaHouston$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.